Hypertonic saline solution

DRUG5 trials

Sponsors

Hospital Clinic of Barcelona, Neuromed IRCCS, Hala Abd EL-Tawab Ibrahim Radwan, University of Monastir, Nantes University Hospital

Conditions

Acute Decompensated Heart FailureBronchiectasisCerebral EdemaHepatic AscitesIntracranial HypertensionTBI Traumatic Brain Injury

Phase 2

Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites

CompletedNCT04785755

Hala Abd EL-Tawab Ibrahim RadwanHepatic Ascites

Start: 2017-11-30End: 2020-04-30Updated: 2021-03-08

Phase 3

Efficacy of Early Continuous Infusion of HSS on the Neurological Outcome at 6 Months in TBI Patients.

Not yet recruitingNCT07319208

Nantes University HospitalTBI Traumatic Brain Injury

Start: 2026-01-01End: 2029-02-01Target: 760Updated: 2026-01-06

Unknown Phase

Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis

CompletedNCT02392663

Hospital Clinic of BarcelonaBronchiectasis

Start: 2015-03-31End: 2016-01-31Updated: 2016-11-15

Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension

WithdrawnNCT03409237

Neuromed IRCCSCerebral Edema, Intracranial Hypertension

Start: 2020-12-03End: 2021-12-31Updated: 2020-11-19

Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure

University of MonastirAcute Decompensated Heart Failure

Start: 2018-07-01End: 2023-09-30Target: 600Updated: 2023-05-16

Related Papers

Impact of hypertonic agents on the solid’s concentration in patients with bronchiectasis. A post-hoc analysis

2023-09-091 citations

Reliability and Minimum Important Difference of Sputum Weight in Bronchiectasis

Respiratory Care2020-02-185 citations